Efficacy and Safety of MCS-5 in Treating Male Oligoasthenospermia

Mise à jour : Il y a 4 ans
Référence : NCT01016340

Extrait

This is a phase II randomized, double-blind, placebo-controlled study where eligible subfertile male subjects (age 20 years).


Critère d'inclusion

  • Male Oligoasthenospermia

Liens